SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Nephro Care India Ltd

BSE: 0 NSE: NEPHROCARE ISIN: INE0SUN01013
  |   Sector:  Healthcare   |   Industry:  Hospital & Healthcare Services

Snapshot

Q.1 Which industry/sub-sector does Nephro Care India Ltd belong to?
Nephro Care India Ltd belongs to the Healthcare sector, operating specifically within the Hospital & Healthcare Services segment.
Q.2 Is Nephro Care India Ltd a good quality company?
Nephro Care India Ltd is a average quality company, based on a somewhat consistent 10 year financial track record.
Q.3 Is Nephro Care India Ltd undervalued or overvalued?
Nephro Care India Ltd appears Undervalued, as its key valuation ratios are below with their past averages.
Q.4 Is Nephro Care India Ltd a good buy now?
Nephro Care India Ltd is a good buy now, based on strong price trend analysis suggesting prices may rise. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Nephro Care India Ltd?
Nephro Care India Ltd revenue growth is 69% for FY-2025 , which is above its 5 year CAGR of 0% , indicating faster growth.
Q.2 Gross Profit margin of Nephro Care India Ltd?
Nephro Care India Ltd Gross profit margin which is the profit after deduction of direct costs, is 15.8% for FY-2025 , which is in line with its 5 year median of 15.8% , indicating stable margins.
Q.3 Operating Profit Margin of Nephro Care India Ltd?
Nephro Care India Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 12.76% for FY-2025 , which is in line with its 5 year median of 12.76% indicating stable margins.
Q.4 Net Profit Margin of Nephro Care India Ltd?
Nephro Care India Ltd Net Profit Margin is 7.91% for FY-2025 , is in line with with its 5 year median of 7.91%, indicating stable margins.
Current Level Historic Median
Gross Profit Margin 15.8 15.8
Operating Profit Margin 12.76 12.76
Net Profit Margin 7.91 7.91
Q.5 Return on Asset of Nephro Care India Ltd?
Nephro Care India Ltd Return on Asset is 8.16%, which is in line with its 5 year historical median of 8.16%, indicating stable asset utilization efficiency.
Q.6 Return on Equity (ROE) of Nephro Care India Ltd?
Nephro Care India Ltd Return on equity is 10.62% for FY-2025 , which is below its historical median of 51.3%, indicating the business is making worse use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Nephro Care India Ltd?
Nephro Care India Ltd Return on capital employed is 14.42% for FY-2025 , which is above its estimated weighted average cost of capital(WACC) 14%, indicating value creation.
Q.8 Cash conversion cycle of Nephro Care India Ltd?
Nephro Care India Ltd Cash conversion cycle is -9 days, above its historical median of -10 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 1.03 1.62
ROE 10.62 51.3
ROCE 14.42 21.11
Cash Conversion Cycle -9 days -10 days
Q.9 Debt to Equity ratio of Nephro Care India Ltd?
Nephro Care India Ltd Debt-to-Equity ratio is 0.00 , which is lower with the industry average of 0.22 , indicating lower debt levels in the industry.
Q.10 Debt to cash flow from operations of Nephro Care India Ltd?
Nephro Care India Ltd Debt to cash flow from operations is 0 , which is at a healthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Nephro Care India Ltd?
Promoters hold 61.71% of the Nephro Care India Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Nephro Care India Ltd vs industry peers?
Nephro Care India Ltd revenue CAGR is 0.00% , compared to the industry median CAGR of 1.49% , indicating slower growth and losing its market share.
Profit Metrics
Current Level Industry Median
Revenue 46 144
Gross Profit 7.3 8.2
Operating Profit 6 8.4
Net Profit 4 5
Operating Efficiency
Current Level Industry Median
Asset Turnover 1.03 0.73
ROE 10.62 13.88
ROCE 14.42 17.77
Cash Conversion Cycle (days) -8.9 2

Valuation & price assessment

Q.1 Stock return of Nephro Care India Ltd over the last decade?
Over the last 1 year(s), the stock has delivered a CAGR of -46.33% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price - - - -46.3%
Q.3 Valuation ratios of Nephro Care India Ltd vs historical?
The current P/E is lower that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 37.63 48.42 79.71
Price to Book 2.54 3.87 3.54
Price to Sales 2.97 8.01 4.37
EV to EBITDA 17.87 31.70 18.04

Check more companies

1. Aster DM Healthcare
2. Global Health
3. Krishna Inst.Medi
4. Dr. Lal Pathlabs
5. Dr. Agarwals Health
6. RainbowChildrenS Med
7. Vijaya Diagnostic
8. Metropolis Health.
9. Park Medi World
10. HealthcareGlobal
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×